º´¿ë±Ý±â: µÎ °³ ÀÌ»óÀÇ ¾à¹°À» °°ÀÌ Åõ¿©ÇßÀ» ¶§ ¿¹»óÇÏÁö ¸øÇÑ ÀÌ»ó¹ÝÀÀÀÌ ³ªÅ¸³ª°Å³ª Ä¡·áÈ¿°úÀÇ »ó½ÇÀ» ÃÊ·¡ÇÏ´Â ¾à¹°.
  
°Ë»ö°á°ú: ÃÑ 26°³ Áß 21 - 30

ºÎ±¤Æä´ÏÅäÀÎĸ½¶100mg(Æä´ÏÅäÀÎ)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°

Á¦Ç°¸í¡å¼ººÐ¸íÁÖ¼ººÐÄÚµåÇ¥ÁØÄÚµåÆǸŻç°í½Ã¹øÈ£Àû¿ëÀÏ
¾Ë·»½Ãĸ½¶75¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(75mg/1ĸ½¶)palbociclib655201ACH641807240±¤µ¿Á¦¾à(ÁÖ)2018008820181102
¾Ë·»½Ãĸ½¶125¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(0.125g/1ĸ½¶)palbociclib655202ACH641807260±¤µ¿Á¦¾à(ÁÖ)2018008820181102
¾Ë·»½Ãĸ½¶100¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(0.1g/1ĸ½¶)palbociclib655203ACH641807250±¤µ¿Á¦¾à(ÁÖ)2018008820181102
¼Ò¹ßµðÁ¤(¼ÒÆ÷½ººÎºñ¸£)_(0.4g/1Á¤)sofosbuvir644401ATB625900050±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯)2017008620171106
¸¶ºñ·¿Á¤_(1Á¤)glecaprevir669700ATB624900290Çѱ¹¾Öºêºñ(ÁÖ)2020013020201228
¸¶ºñ·¿Á¤_(1Á¤)pibrentasvir669700ATB624900290Çѱ¹¾Öºêºñ(ÁÖ)2020013020201228
´ÙºñÆ®¶õĸ½¶150¹Ð¸®±×·¥(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.17295g/1ĸ½¶)dabigatran etexilate mesylate (as dabigatran etexilate)613702ACH654005040¾ÆÁÖ¾àÇ°(ÁÖ)2018008820181102
´ÙºñÆ®¶õĸ½¶110¹Ð¸®±×·¥(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.12683g/1ĸ½¶)dabigatran etexilate mesylate (as dabigatran etexilate)613701ACH654005030¾ÆÁÖ¾àÇ°(ÁÖ)2018008820181102
´Ùºñĭĸ½¶150mg(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.17295g/1ĸ½¶)dabigatran etexilate mesylate (as dabigatran etexilate)613702ACH052400700(ÁÖ)ÀÎÆ®·Î¹ÙÀÌ¿ÀÆĸ¶2018008820181102
´Ùºñĭĸ½¶110mg(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.12683g/1ĸ½¶)dabigatran etexilate mesylate (as dabigatran etexilate)613701ACH052400680(ÁÖ)ÀÎÆ®·Î¹ÙÀÌ¿ÀÆĸ¶2018008820181102